Medios AG (LON: 0QB4)

Market Cap	259.75M
Revenue (ttm)	1.53B
Net Income (ttm)	10.71M
Shares Out	n/a
EPS (ttm)	0.44
PE Ratio	24.24
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	975
Average Volume	18,838
Open	12.00
Previous Close	12.02
Day's Range	12.00 - 12.08
52-Week Range	12.00 - 20.60
Beta	1.06
RSI	38.27
Earnings Date	Mar 28, 2025

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, p...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2016
• Employees: 515
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QB4

Financial Performance

In 2023, Medios AG's revenue was 1.78 billion, an increase of 10.71% compared to the previous year's 1.61 billion. Earnings were 18.81 million, an increase of 2.62%.

Financial numbers in EUR